UK markets closed

HCA Healthcare, Inc. (0J1R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
310.59+2.19 (+0.71%)
At close: 04:42PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 328.03%
S&P500 52-week change 322.38%
52-week high 3328.79
52-week low 3216.00
50-day moving average 3300.67
200-day moving average 3273.20

Share statistics

Avg vol (3-month) 31.01k
Avg vol (10-day) 31.96k
Shares outstanding 5344.16M
Implied shares outstanding 6N/A
Float 8189.4M
% held by insiders 127.49%
% held by institutions 165.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.46
Trailing annual dividend yield 30.80%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.20%
Operating margin (ttm)14.76%

Management effectiveness

Return on assets (ttm)11.12%
Return on equity (ttm)845.54%

Income statement

Revenue (ttm)66.72B
Revenue per share (ttm)247.75
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 12.87B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)21.29
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)1.38B
Total cash per share (mrq)5.26
Total debt (mrq)42.1B
Total debt/equity (mrq)3,315.20%
Current ratio (mrq)1.16
Book value per share (mrq)-6.14

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)3.78B